The concept of "Qianjin vinesu" was born, and the concept stocks of Qianjin vines opened higher and strengthened. Post date May 17, 2022 — 12:07 Post Lock Read More Soochow Securities: VV116 preparation and its industrial chain have a large market space Post date May 17, 2022 — 10:41 Post Lock Read More Kaiyuan Securities: Buy rating on Porton shares Post date May 17, 2022 — 10:13 Post Lock Read More The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More Kaiyuan Securities gives Porton shares a buy rating: building an end-to-end CDMO service platform company to buy a new development cycle – yqqlm Post date May 17, 2022 — 08:30 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Soochow Securities: VV116 preparation and its industrial chain have a large market space Post date May 17, 2022 — 10:41 Post Lock Read More Kaiyuan Securities: Buy rating on Porton shares Post date May 17, 2022 — 10:13 Post Lock Read More The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More Kaiyuan Securities gives Porton shares a buy rating: building an end-to-end CDMO service platform company to buy a new development cycle – yqqlm Post date May 17, 2022 — 08:30 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kaiyuan Securities: Buy rating on Porton shares Post date May 17, 2022 — 10:13 Post Lock Read More The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More Kaiyuan Securities gives Porton shares a buy rating: building an end-to-end CDMO service platform company to buy a new development cycle – yqqlm Post date May 17, 2022 — 08:30 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype is crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: say you have it and you will have it – yqqlm Post date May 17, 2022 — 09:33 Post Lock Read More Kaiyuan Securities gives Porton shares a buy rating: building an end-to-end CDMO service platform company to buy a new development cycle – yqqlm Post date May 17, 2022 — 08:30 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kaiyuan Securities gives Porton shares a buy rating: building an end-to-end CDMO service platform company to buy a new development cycle – yqqlm Post date May 17, 2022 — 08:30 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: If you have it, you will have every Jingwang Post date May 17, 2022 — 04:08 Post Lock Read More News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
News｜Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN Post date May 17, 2022 — 02:56 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu, investors: if you have it, you will have it Post date May 17, 2022 — 02:08 Post Lock Read More The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The hype of "Qianjintansu" is too crazy! This company clarifies that it has nothing to do with Qianjintansu: say you have it and you will have it – yqqlm Post date May 17, 2022 — 02:06 Post Lock Read More Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval Post date May 16, 2022 — 23:17 Post Lock Read More Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Highlights of the announcement on the evening of May 16: Qianjin Pharmaceutical clarifies that the company does not have the production and sales of Qianjin Post date May 16, 2022 — 21:47 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 20:13 Post Lock Read More Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology Post date May 16, 2022 — 20:07 Post Lock Read More Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation Post date May 16, 2022 — 19:52 Post Lock Read More The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug Post date May 16, 2022 — 17:30 Post Lock Read More Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue Post date May 16, 2022 — 11:23 Post Lock Read More Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The research results of Hengrui Medicine's PD-L1 inhibitor adebelimumab appear in The Lancet Oncology, which is expected to bring new options for patients with small cell lung cancer Post date May 15, 2022 — 08:35 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Is the efficacy of fenugreek, which claims to be the best in suppressing the new crown virus, exaggerated? Post date May 14, 2022 — 17:46 Post Lock Read More
Caishen.CoCaishen.Co